Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-28

Clinical Trial Update: Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs ) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety of co-administration of IDA and azithromycin for neglected tropical diseases (trachoma and yaws, with related con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • IDA (Ivermectin + Diethylcarbamazine + Albendazole)

Snippet

Sponsor: Lihir Medical Centre | Conditions: Trachoma, Yaws | Phase 3 | Status: COMPLETED